Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.
about
The Origin and Activities of IgA1-Containing Immune Complexes in IgA NephropathyEnzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathyRegulation of T Cell Trafficking by Enzymatic Synthesis of O-Glycans.The genetics and immunobiology of IgA nephropathy.Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin A (IgA) nephropathy and healthy individualsN-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.DNA methylation in Cosmc promoter region and aberrantly glycosylated IgA1 associated with pediatric IgA nephropathy.Development of Animal Models of Human IgA NephropathyNovel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathyNew Insights into the Pathogenesis of IgA Nephropathy.GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathwayToward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study.Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.Diagnosis and activity assessment of immunoglobulin A nephropathy: current perspectives on noninvasive testing with aberrantly glycosylated immunoglobulin A-related biomarkers.Biomarkers in IgA nephropathy.Paradigm shift in activity assessment of IgA nephropathy - optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting.The Role of TNF Superfamily Member 13 in the Progression of IgA Nephropathy.Markers for the progression of IgA nephropathy.IgA nephropathy enigma.Toll-Like Receptor 9 Stimulation Induces Aberrant Expression of a Proliferation-Inducing Ligand by Tonsillar Germinal Center B Cells in IgA Nephropathy.Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?Galactosylation of IgA1 Is Associated with Common Variation in C1GALT1.What Genetics Tells Us About the Pathogenesis of IgA Nephropathy: The Role of Immune Factors and Infection.A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction.Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy.Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy.Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patientsThe Emerging Role of Pathogenesis of IgA NephropathyExtracellular galectins as controllers of cytokines in hematological cancer
P2860
Q26752555-8DA56E1F-FCBD-49DA-A689-E81E019EEB4AQ28539595-2749FBD7-8C69-4161-B0B1-0B3DE8F7EE01Q33720307-A6D11EEA-DE2B-4E1A-8DC8-BA94F3FB1C1BQ33872517-7D83DF76-0D72-40F1-874F-16ED789BAB01Q34468379-B5905BDB-10E2-46D7-864A-DE1B6DF35328Q35022256-63D41C91-A17F-4119-90A9-D1E9D0C5F3B0Q35043308-5BF4A74C-FDDA-4F91-9FCD-79CAE6D50551Q35110061-C1CB0108-3612-4308-B9D6-2951EEAB6E48Q35886028-D84007D2-17DA-4B5F-9DA9-F15CE2C7D090Q36267833-464D1786-353D-48ED-A8F9-D2F3DBED0996Q36276884-49A35A88-1079-4DFC-8C9B-91A120B5948EQ37359092-65929B43-A546-4953-B2EC-E81A4DFCAA23Q38242833-4E93D45F-C194-4AEB-85A2-D230D89C2BA1Q38266027-74C847B2-FE5D-424F-8639-92727FF77C44Q38294669-57DE6D87-CCCF-440D-A651-3DE5484B91B3Q38325438-972D8F74-942A-4755-8188-3005B41A820CQ38409163-33D9D2DF-F816-48FB-8448-876A08770B50Q38824816-D1EE6BF6-C585-4211-A913-EE3849548F46Q38904812-9C10079E-E52E-4A2E-9344-0BA85031A687Q39128596-345AF719-8AD0-44F0-92C2-E144E9FBF782Q39372098-637C5CDD-F112-41E5-9FB2-39650347BC4FQ40328922-B48F2B07-D15E-4C7D-9BD8-C4044A644470Q45420903-F09BF132-B475-4C06-8895-2ACE2F0C2804Q46606282-20CB24FE-850B-4F40-9585-BE57D01B6295Q47116206-17A8DFE4-026E-4BB2-8D64-3D64B211CD6FQ48258967-6C3C3512-84C9-411E-8007-7CD89930DFC8Q51611781-08D5F3C2-0545-4A1B-BB9A-BA86E16B2617Q57171624-97AC18AD-3BCA-4836-946E-B065A2C1728AQ58734688-8EC459B9-3D0C-4A33-A9C4-D4A04F8591C5Q58803547-9FFF1279-51D8-41CB-8ACA-F7C3FE653F7F
P2860
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.
@en
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.
@nl
type
label
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.
@en
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.
@nl
prefLabel
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.
@en
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.
@nl
P2093
P2860
P356
P1476
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes
@en
P2093
Ali G Gharavi
Bruce A Julian
Hitoshi Suzuki
Koshi Yamada
Yasuhiko Tomino
Zina Moldoveanu
P2860
P304
P356
10.1074/JBC.M113.512277
P407
P577
2014-01-07T00:00:00Z